Your browser doesn't support javascript.
loading
TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.
Teramachi, Jumpei; Tenshin, Hirofumi; Hiasa, Masahiro; Oda, Asuka; Bat-Erdene, Ariunzaya; Harada, Takeshi; Nakamura, Shingen; Ashtar, Mohannad; Shimizu, So; Iwasa, Masami; Sogabe, Kimiko; Oura, Masahiro; Fujii, Shiro; Kagawa, Kumiko; Miki, Hirokazu; Endo, Itsuro; Haneji, Tatsuji; Matsumoto, Toshio; Abe, Masahiro.
Afiliación
  • Teramachi J; Dept. of Histology-Oral Histology and Dept. of Hematology, Tokushima University,Tokushima, Japan.
  • Tenshin H; Dept. of Hematology and Orthodontics and Dentofacial Orthopedics,Tokushima University, Japan.
  • Hiasa M; Dept. of Hematology and Orthodontics and Dentofacial Orthopedics,Tokushima University, Japan.
  • Oda A; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Bat-Erdene A; Dept of Hematology, Tokushima University and University of Medical Sciences, Ulaanbaatar, Mongolia.
  • Harada T; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Nakamura S; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Ashtar M; Dept. of Hematology and Orthodontics and Dentofacial Orthopedics,Tokushima University, Japan.
  • Shimizu S; Dept. of Hematology and Orthodontics and Dentofacial Orthopedics,Tokushima University, Japan.
  • Iwasa M; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Sogabe K; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Oura M; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Fujii S; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Kagawa K; Department of Hematology, Tokushima University, Tokushima, Japan.
  • Miki H; Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan.
  • Endo I; Department of Chronomedicine, Tokushima University, Tokushima, Japan.
  • Haneji T; Department of Histology and Oral Histology, Tokushima University, Tokushima, Japan.
  • Matsumoto T; Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan.
  • Abe M; Department of Hematology, Tokushima University, Tokushima, Japan.
Haematologica ; 106(5): 1401-1413, 2021 05 01.
Article en En | MEDLINE | ID: mdl-32273474
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteólisis / Quinasas Quinasa Quinasa PAM / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteólisis / Quinasas Quinasa Quinasa PAM / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Italia